AGEN

AgenusF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

AGEN vs peer average

31/100

AGEN vs. peer average (F vs. D)

Grade spread

A 2 · C 1 · D 2 · F 5

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

AARD is the first available peer comparator.

Aardvark Therapeutics is a packet-identified same-sector, similar-market-cap biotech comparator, but it should be used only as a small-cap clinical-development and financing-risk reference rather than as a direct BOT+BAL oncology peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAARDAardvark Therapeutics

AGEN

Agenus

AARD

Aardvark Therapeutics

Grade

N/A

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Defensive

Unrated

Open Side-by-Side Comparison Compare all

Grade position vs AARD

AGEN / AARD

Grade Position

Below peers

AGEN vs. peer average (F vs. D)

31/100

Momentum

AGEN

Value

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs AGEN

AARD

N/A

GALT

20/100

Even

GNLX

40/100

-1

CRBP

Corbus Pharmaceuticals Holdings Inc Common

40/100

-1

HURA

TuHURA Biosciences Inc Common

100/100

-4

AARD is the first peer returned for this comparison set.